Premium
HIGH‐RISK PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA ARE NOT ENROLLED ON CLINICAL TRIALS
Author(s) -
Reagan P.,
Loh K.P.,
Baran A.,
Hu J.,
Casulo C.,
Barr P.M.,
Friedberg J.W.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2438_42
Subject(s) - medicine , clinical trial , diffuse large b cell lymphoma , progression free survival , oncology , lymphoma , overall survival